Your browser doesn't support javascript.
loading
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked.
Bodor, J Nicholas; Patel, Jyoti D; Wakelee, Heather A; Levy, Benjamin P; Borghaei, Hossein; Pellini, Bruna; Costello, Michael R; Dowell, Jonathan E; Finley, Gene; Huang, Chao H; Neal, Joel W; Nieva, Jorge J; Puri, Sonam; Socinski, Mark A; Thomas, Christian; Ross, Eric A; Litwin, Samuel; Clapper, Margie L; Treat, Joseph.
Afiliación
  • Bodor JN; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Patel JD; Hematology Oncology Division, Northwestern University, Chicago, IL.
  • Wakelee HA; Department of Medical Oncology, Stanford Cancer Institute, Stanford, CA.
  • Levy BP; Department of Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center, Washington, DC.
  • Borghaei H; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Pellini B; Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL.
  • Costello MR; Department of Hematology/Oncology, University of Pennsylvania Abramson Cancer Center at Chester County Hospital, West Chester, PA.
  • Dowell JE; Department of Hematology/Oncology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas, TX.
  • Finley G; Department of Medical Oncology, Allegheny Health Network, Pittsburgh, PA.
  • Huang CH; Department of Medical Oncology, University of Kansas Medical Center, Kansas City, KS.
  • Neal JW; Department of Medical Oncology, Stanford Cancer Institute, Stanford, CA.
  • Nieva JJ; Department of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA.
  • Puri S; Division of Oncology, University of Utah Huntsman Cancer Institute, Salt Lake City, UT.
  • Socinski MA; Department of Medical Oncology, AdventHealth Cancer Institute, Orlando, FL.
  • Thomas C; New England Cancer Specialists, Scarborough, ME.
  • Ross EA; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Litwin S; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Clapper ML; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA.
  • Treat J; Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA. Electronic address: joseph.treat2@fccc.edu.
Clin Lung Cancer ; 24(7): e242-e246, 2023 11.
Article en En | MEDLINE | ID: mdl-37451930
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article